WallStreetZenWallStreetZen

NASDAQ: XERS
Xeris Biopharma Holdings Inc Stock Ownership - Who owns Xeris Biopharma Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xeris Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin McCullochCOO;Pres2026-09-0115,000$8.49
$127.31kSell
Beth HechtCLO;Sec2026-09-0116,666$8.49
$141.43kSell
Steven PieperCFO2026-09-015,000$8.50
$42.50kSell
Steven PieperCFO2026-08-125,000$8.50
$42.50kSell
Kevin McCullochCOO;Pres2026-08-0315,000$8.02
$120.24kSell
Beth HechtCLO;Sec2026-08-0316,666$8.01
$133.56kSell
John Patrick Shannon Jr.CEO;Chair2026-08-0136,645$8.08
$296.09kSell
Kevin McCullochCOO;Pres2026-08-0121,918$8.08
$177.10kSell
Steven PieperChief Financial Officer2026-07-0727,600$8.52
$235.26kSell
Steven PieperChief Financial Officer2026-07-0617,400$8.50
$147.90kSell

1 of 6

XERS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XERS insiders and whales buy or sell their stock.

XERS Shareholders

What type of owners hold Xeris Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC2.97%5,413,284$44.39MInsider
Paul R. Edick2.12%3,868,354$31.72MInsider
John Patrick Shannon Jr.1.59%2,898,933$23.77MInsider
James E. Flynn1.29%2,355,136$19.31MInsider
Palmetto Partners Ltd1.16%2,110,061$17.30MInsider
Kevin McCulloch0.93%1,691,208$13.87MInsider
Steven Pieper0.74%1,356,053$11.12MInsider
Beth Hecht0.62%1,127,796$9.25MInsider
Steven Prestrelski0.39%719,780$5.90MInsider
John Johnson0.39%707,276$5.80MInsider

1 of 3

XERS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XERS0.06%13.43%Net SellingNet Selling
LTGO0.00%28.86%Net BuyingNet Buying
BCAX0.11%31.92%Net BuyingNet Selling
INVA0.10%69.14%Net BuyingNet Selling
TYRA0.12%57.28%Net SellingNet Buying
View Top Biotech Stocks

Xeris Biopharma Holdings Stock Ownership FAQ

Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings (NASDAQ: XERS) is owned by 0.06% institutional shareholders, 13.43% Xeris Biopharma Holdings insiders, and 86.51% retail investors. Redmile Group LLC is the largest individual Xeris Biopharma Holdings shareholder, owning 5.41M shares representing 2.97% of the company. Redmile Group LLC's Xeris Biopharma Holdings shares are currently valued at $44.39M.

If you're new to stock investing, here's how to buy Xeris Biopharma Holdings stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.